---
title: "Sorting screens"
author: "Dian Li, Wubing Zhang, Zexian Davis Zeng"
date: "`r Sys.Date()`"
output: 
  workflowr::wflow_html:
    toc: true
    number_sections: true
    toc_depth: 1
    df_print: paged
    css: style.css
    toc_float:
      collapsed: false
editor_options:
  chunk_output_type: console
---

# Positive control
**Description**: CRISPR screens with _Soring_ condition using a list of positive control genes. Positive LFC values indicate genes whose knockout can increase the correponding protein expression level<br />

```{r, echo=FALSE, out.width='100%', fig.align='left', fig.cap=''}
knitr::include_graphics("assets/positive_control_final/QC_Heatmap_scaled_sorting.svg", error = FALSE)
```

-----

# 26189680 | AvivRegev | Cell | 2015 | BMDCs | TNF
## **Overview** 
**PMID**: 26189680<br />
**Model**: Bone marrow derived dendritic cells (BMDCs)<br />
**Treatment**: After CRISPR screen, BMDCs were sorted with high tumor necrosis factor (TNF) expression level<br />
**Control**: Sorted with low tumor necrosis factor (TNF) level<br />
**Type**: Sorting <br />
**Description**: CRISPR screen in mouse bone marrow derived dendritic cells (BMDCs) and sorted with TNF high vs. TNF low conditions. Positive LFC values indicate genes whose knockout can increase TNF protein expression level<br />

## **Original Figures**
<!-- #### Figure -->
```{r, echo=FALSE, out.width='75%', fig.align='left', fig.cap=''}
knitr::include_graphics("assets/original_fig/26189680_AvivRegev_Cell_2015_BMDCs_TNF_Sorting_DC.png", error = FALSE)
```

-----

## **MAGeCK-VISPR Results** {.tabset}
### Processed - Rank Plot
```{r, echo=FALSE, out.width='75%', fig.align='left', fig.cap=''}
knitr::include_graphics('assets/median_scaled_QC/RankPlot/26189680_AvivRegev_Cell_2015_BMDCs_TNF_Sorting_DC.png', error = FALSE)
```

-----

### Raw - Rank Plot
```{r, echo=FALSE, out.width='75%', fig.align='left', fig.cap=''}
knitr::include_graphics('assets/RRA_QC/RankPlot/26189680_AvivRegev_Cell_2015_BMDCs_TNF_EX1_Sorting_DC.png', error = FALSE)
knitr::include_graphics('assets/RRA_QC/RankPlot/26189680_AvivRegev_Cell_2015_BMDCs_TNF_EX2_Sorting_DC.png', error = FALSE)
knitr::include_graphics('assets/RRA_QC/RankPlot/26189680_AvivRegev_Cell_2015_BMDCs_TNF_EX3_Sorting_DC.png', error = FALSE)
```

-----

### Raw - Volcano Plot
```{r, echo=FALSE, out.width='75%', fig.align='left', fig.cap=''}
knitr::include_graphics('assets/RRA_QC/VolcanoPlot/26189680_AvivRegev_Cell_2015_BMDCs_TNF_EX1_Sorting_DC.png', error = FALSE)
knitr::include_graphics('assets/RRA_QC/VolcanoPlot/26189680_AvivRegev_Cell_2015_BMDCs_TNF_EX2_Sorting_DC.png', error = FALSE)
knitr::include_graphics('assets/RRA_QC/VolcanoPlot/26189680_AvivRegev_Cell_2015_BMDCs_TNF_EX3_Sorting_DC.png', error = FALSE)
```

-----

# 28813417 | MarkADawson | Nature | 2017 | BxPC-3 | PD-L1
## **Overview**
**PMID**: 28813417<br />
**Model**: BxPC-3 (human pancreatic cancer cell line)<br />
**Treatment**: After interferon gamma treatment and CRISPR screen, BxPC-3 cells were sorted with PD-L1_low surface marker; After CRISPR screen, BxPC-3 cells were sorted with PD-L1_low surface marker<br />
**Control**: Input<br />
**Type**: Sorting<br />
**Description**: CRISPR screen in human pancreatic cancer cell line BxPC-3 and sorted with PD-L1 low conditions. Positive LFC values indicate genes whose knockout can decrease PD-L1 protein expression level<br />

## **Original Figures**
```{r, echo=FALSE, out.width='85%', fig.align='left', fig.cap=''}
knitr::include_graphics("assets/original_fig/28813417_MarkADawson_Nature_2017.png", error = FALSE)
```
```{r, echo=FALSE, out.width='35%', fig.align='left', fig.cap=''}
knitr::include_graphics("assets/original_fig/28813417_MarkADawson_Nature_2017_BxPC-3_PD-L1.High.IFNg-.png", error = FALSE)
```
```{r, echo=FALSE, out.width='45%', fig.align='left', fig.cap=''}
knitr::include_graphics("assets/original_fig/28813417_MarkADawson_Nature_2017_BxPC-3_PD-L1.High.IFNg.png", error = FALSE)
```

-----

## **MAGeCK-VISPR Results** {.tabset}
### Processed - Rank Plot
Too few genes were selected due to experient protocols. Thus we did not include this dataset to our study.
```{r, echo=FALSE, out.width='75%', fig.align='left', fig.cap=''}
# knitr::include_graphics('assets/median_scaled_QC/RankPlot/', error = FALSE)
```

-----

### Raw - Rank Plot
```{r, echo=FALSE, out.width='75%', fig.align='left', fig.cap=''}
knitr::include_graphics('assets/RRA_QC/RankPlot/28813417_MarkADawson_Nature_2017_BxPC-3_PD-L1.High.IFNg-_Sorting_PAAD.png', error = FALSE)
knitr::include_graphics('assets/RRA_QC/RankPlot/28813417_MarkADawson_Nature_2017_BxPC-3_PD-L1.High.IFNg_Sorting_PAAD.png', error = FALSE)
```

-----

### Raw - Volcano Plot
```{r, echo=FALSE, out.width='75%', fig.align='left', fig.cap=''}
knitr::include_graphics('assets/RRA_QC/VolcanoPlot/28813417_MarkADawson_Nature_2017_BxPC-3_PD-L1.High.IFNg-_Sorting_PAAD.png', error = FALSE)
knitr::include_graphics('assets/RRA_QC/VolcanoPlot/28813417_MarkADawson_Nature_2017_BxPC-3_PD-L1.High.IFNg_Sorting_PAAD.png', error = FALSE)
```

-----

# 30890156 | NamjinChung | BMCGenomics | 2019 | MC38 | PDL1
## **Overview**
**PMID**: 30890156<br />
**Model**: MC38 (murine colon adenocarcinoma cell line)<br />
**Treatment**: After CRISPR screen, MC38 cells were sorted with high PD-L1 expression level<br />
**Control**: Sorted with low PD-L1 expression level<br />
**Type**: Sorting<br />
**Description**: CRISPR screen in mouse colon adenocarcinoma cells MC38 and sorted with PD-L1 high vs. PD-L1 low conditions. Negative LFC values indicate genes whose knockout can decrease PD-L1 protein expression level<br />

## **Original Figures**
```{r, echo=FALSE, out.width='105%', fig.align='left', fig.cap=''}
knitr::include_graphics("assets/original_fig/30890156_NamjinChung_BMCGenomics_2019_MC38_PDL1.overview.png", error = FALSE)
```
```{r, echo=FALSE, out.width='40%', fig.align='left', fig.cap=''}
knitr::include_graphics("assets/original_fig/30890156_NamjinChung_BMCGenomics_2019_MC38_PDL1.png", error = FALSE)
```

-----

## **MAGeCK-VISPR Results** {.tabset}
### Processed - Rank Plot
```{r, echo=FALSE, out.width='75%', fig.align='left', fig.cap=''}
knitr::include_graphics('assets/median_scaled_QC/RankPlot/30890156_NamjinChung_BMCGenomics_2019_MC38_PDL1_Sorting_COAD.png', error = FALSE)
```

-----

### Raw - Rank Plot
```{r, echo=FALSE, out.width='75%', fig.align='left', fig.cap=''}
knitr::include_graphics('assets/RRA_QC/RankPlot/30890156_NamjinChung_BMCGenomics_2019_MC38_PDL1_Sorting_COAD.png', error = FALSE)
```

-----

### Raw - Volcano Plot
```{r, echo=FALSE, out.width='75%', fig.align='left', fig.cap=''}
knitr::include_graphics('assets/RRA_QC/VolcanoPlot/30890156_NamjinChung_BMCGenomics_2019_MC38_PDL1_Sorting_COAD.png', error = FALSE)
```

-----

# 31365872 | BenjaminEGewurz | CellRep | 2019 | DaudiB | CD40
## **Overview**
**PMID**: 31365872<br />
**Model**: Daudi (human B lymphoblast cell)<br />
**Treatment**: After CRISPR screen, Daudi B cells were sorted with high CD40 expression level<br />
**Control**: Sorted with low CD40 expression level<br />
**Type**: Sorting<br />
**Description**: CRISPR screen in human B lymphoblast Daudi cells and sorted with CD40 high vs. CD40 low conditions. Positive LFC values indicate genes whose knockout can increase CD40 protein expression level<br />

## **Original Figures**
```{r, echo=FALSE, out.width='55%', fig.align='left', fig.cap=''}
knitr::include_graphics("assets/original_fig/31365872_BenjaminEGewurz_CellRep_2019_DaudiB_CD40_Sorting.overview.png", error = FALSE)
```
```{r, echo=FALSE, out.width='85%', fig.align='left', fig.cap=''}
knitr::include_graphics("assets/original_fig/31365872_BenjaminEGewurz_CellRep_2019_DaudiB_CD40_Sorting.png", error = FALSE)
```

-----

## **MAGeCK-VISPR Results** {.tabset}
### Processed - Rank Plot
```{r, echo=FALSE, out.width='75%', fig.align='left', fig.cap=''}
knitr::include_graphics('assets/median_scaled_QC/RankPlot/31365872_BenjaminEGewurz_CellRep_2019_DaudiB_CD40_Sorting_B-cell.png', error = FALSE)
```

-----

### Raw - Rank Plot
```{r, echo=FALSE, out.width='75%', fig.align='left', fig.cap=''}
knitr::include_graphics('assets/RRA_QC/RankPlot/31365872_BenjaminEGewurz_CellRep_2019_DaudiB_CD40_r12_Sorting_B-cell.png', error = FALSE)
knitr::include_graphics('assets/RRA_QC/RankPlot/31365872_BenjaminEGewurz_CellRep_2019_DaudiB_CD40_r34_Sorting_B-cell.png', error = FALSE)
```

-----

### Raw - Volcano Plot
```{r, echo=FALSE, out.width='75%', fig.align='left', fig.cap=''}
knitr::include_graphics('assets/RRA_QC/VolcanoPlot/31365872_BenjaminEGewurz_CellRep_2019_DaudiB_CD40_r12_Sorting_B-cell.png', error = FALSE)
knitr::include_graphics('assets/RRA_QC/VolcanoPlot/31365872_BenjaminEGewurz_CellRep_2019_DaudiB_CD40_r34_Sorting_B-cell.png', error = FALSE)
```

-----

# 31452512 | JeffreySettleman | Elife | 2019 | K562 | MHCI
## **Overview**
**PMID**: 31452512<br />
**Model**: K562 (human chronic myelogenous leukemia cell line)<br />
**Treatment**: After CRISPR screen, K562 cells were sorted with high MHC-I expression level<br />
**Control**: Sorted with low MHC-I expression level<br />
**Type**: Sorting<br />
**Description**: CRISPR screen in human chronic myelogenous leukemia cells K562 and sorted with MHC-I high vs. MHC-I low conditions. Positive LFC values indicate genes whose knockout can increase MHC-I protein expression level<br />

## **Original Figures**
```{r, echo=FALSE, out.width='85%', fig.align='left', fig.cap=''}
knitr::include_graphics("assets/original_fig/31452512_JeffreySettleman_Elife_2019_K562_MHCI_Sorting_LCML.png", error = FALSE)
```

-----

## **MAGeCK-VISPR Results** {.tabset}
### Processed - Rank Plot
```{r, echo=FALSE, out.width='75%', fig.align='left', fig.cap=''}
knitr::include_graphics('assets/median_scaled_QC/RankPlot/31452512_JeffreySettleman_Elife_2019_K562_MHCI_Sorting_LCML.png', error = FALSE)
```

-----

### Raw - Rank Plot
```{r, echo=FALSE, out.width='75%', fig.align='left', fig.cap=''}
knitr::include_graphics('assets/RRA_QC/RankPlot/31452512_JeffreySettleman_Elife_2019_K562_MHCI_r1_Sorting_LCML.png', error = FALSE)
knitr::include_graphics('assets/RRA_QC/RankPlot/31452512_JeffreySettleman_Elife_2019_K562_MHCI_r2_Sorting_LCML.png', error = FALSE)
```

-----

### Raw - Volcano Plot
```{r, echo=FALSE, out.width='75%', fig.align='left', fig.cap=''}
knitr::include_graphics('assets/RRA_QC/VolcanoPlot/31452512_JeffreySettleman_Elife_2019_K562_MHCI_r1_Sorting_LCML.png', error = FALSE)
knitr::include_graphics('assets/RRA_QC/VolcanoPlot/31452512_JeffreySettleman_Elife_2019_K562_MHCI_r2_Sorting_LCML.png', error = FALSE)
```

-----

# 31509742 | JaneOliaro | CellRep | 2019 | B16F10 | MHCI.low
## **Overview**
**PMID**: 31509742<br />
**Model**: B16F10 (murine skin melanoma cell line)<br />
**Treatment**: After CRISPR screen, B16F10 cells were sorted with low MHC-I expression level<br />
**Control**: T0 unsorted<br />
**Type**: Sorting<br />
**Description**: CRISPR screen in mouse skin cancer cells B16F10 and sorted with MHC-I low vs. T0 unsorted conditions. Negative LFC values indicate genes whose knockout can decrease MHC-I protein expression level<br />

## **Original Figures**
```{r, echo=FALSE, out.width='105%', fig.align='left', fig.cap=''}
knitr::include_graphics("assets/original_fig/31509742_JaneOliaro_CellRep_2019_B16F10_MHCI.Low.overview.png", error = FALSE)
```
```{r, echo=FALSE, out.width='85%', fig.align='left', fig.cap=''}
knitr::include_graphics("assets/original_fig/31509742_JaneOliaro_CellRep_2019_B16F10_MHCI.Low.png", error = FALSE)
```

-----

## **MAGeCK-VISPR Results** {.tabset}
### Processed - Rank Plot
```{r, echo=FALSE, out.width='75%', fig.align='left', fig.cap=''}
knitr::include_graphics('assets/median_scaled_QC/RankPlot/31509742_JaneOliaro_CellRep_2019_B16F10_MHCI.Low_Sorting_SKCM.png', error = FALSE)
```

-----

### Raw - Rank Plot
```{r, echo=FALSE, out.width='75%', fig.align='left', fig.cap=''}
knitr::include_graphics('assets/RRA_QC/RankPlot/31509742_JaneOliaro_CellRep_2019_B16F10_MHCI.Low_Sorting_SKCM.png', error = FALSE)
```

-----

### Raw - Volcano Plot
```{r, echo=FALSE, out.width='75%', fig.align='left', fig.cap=''}
knitr::include_graphics('assets/RRA_QC/VolcanoPlot/31509742_JaneOliaro_CellRep_2019_B16F10_MHCI.Low_Sorting_SKCM.png', error = FALSE)
```

-----

# 31801065 | MeghanHoldorf | CellRep | 2019 | HepG2 | HBsAg
## **Overview**
**PMID**: 31801065<br />
**Model**: HepG2 (human liver cancer cell line)<br />
**Treatment**: After CRISPR screen, HepG2 cells were treated with DMSO and then sorted with high Hepatitis B surface antigen (HBsAg) expression level<br />
**Control**: Sorted with low HBsAg expression level<br />
**Type**: Sorting<br />
**Description**: CRISPR screen in human liver cancer cells HepG2 and sorted with HBsAg high vs. HBsAg low conditions. Negative LFC values indicate genes whose knockout can decrease HBsAg protein expression level<br />

## **Original Figures**
```{r, echo=FALSE, out.width='105%', fig.align='left', fig.cap=''}
knitr::include_graphics("assets/original_fig/31801065_MeghanHoldorf_CellRep_2019_HepG2+DMSO_HBsAg.png", error = FALSE)
```
```{r, echo=FALSE, out.width='85%', fig.align='left', fig.cap=''}
knitr::include_graphics("assets/original_fig/31801065_MeghanHoldorf_CellRep_2019_HepG2+DMSO_HBsAg_table.png", error = FALSE)
```

-----

## **MAGeCK-VISPR Results** {.tabset}
### Processed - Rank Plot
```{r, echo=FALSE, out.width='75%', fig.align='left', fig.cap=''}
knitr::include_graphics('assets/median_scaled_QC/RankPlot/31801065_MeghanHoldorf_CellRep_2019_HepG2_HBsAg_Sorting_LIHC.png', error = FALSE)
```

-----

### Raw - Rank Plot
```{r, echo=FALSE, out.width='75%', fig.align='left', fig.cap=''}
knitr::include_graphics('assets/RRA_QC/RankPlot/31801065_MeghanHoldorf_CellRep_2019_HepG2_HBsAb_Sorting_LIHC.png', error = FALSE)
```

-----

### Raw - Volcano Plot
```{r, echo=FALSE, out.width='75%', fig.align='left', fig.cap=''}
knitr::include_graphics('assets/RRA_QC/VolcanoPlot/31801065_MeghanHoldorf_CellRep_2019_HepG2_HBsAb_Sorting_LIHC.png', error = FALSE)
```

-----

# 31801065 | MeghanHoldorf | CellRep | 2019 | HepG2.RG7834.Lo | HBsAg
## **Overview**
**PMID**: 31801065<br />
**Model**: HepG2 (human liver cancer cell line)<br />
**Treatment**: After CRISPR screen, HepG2 cells were treated with low dose RG7834 (0.03 nM) and then sorted with high Hepatitis B surface antigen (HBsAg) expression level<br />
**Control**: Sorted with low HBsAg expression level<br />
**Type**: Sorting<br />
**Description**: CRISPR screen in human liver cancer cells HepG2 and sorted with HBsAg high vs. HBsAg low conditions. Negative LFC values indicate genes whose knockout can decrease HBsAg protein expression level in the presense of low dose RG7834<br />

## **Original Figures**
```{r, echo=FALSE, out.width='85%', fig.align='left', fig.cap=''}
knitr::include_graphics("assets/original_fig/31801065_MeghanHoldorf_CellRep_2019_HepG2.RG7834.Lo_HBsAg_table.png", error = FALSE)
```

-----

## **MAGeCK-VISPR Results** {.tabset}
### Processed - Rank Plot
```{r, echo=FALSE, out.width='75%', fig.align='left', fig.cap=''}
knitr::include_graphics('assets/median_scaled_QC/RankPlot/31801065_MeghanHoldorf_CellRep_2019_HepG2.RG7834.Lo_HBsAg_Sorting_LIHC.png', error = FALSE)
```

-----

### Raw - Rank Plot
```{r, echo=FALSE, out.width='75%', fig.align='left', fig.cap=''}
knitr::include_graphics('assets/RRA_QC/RankPlot/31801065_MeghanHoldorf_CellRep_2019_HepG2.RG7834.Lo_HBsAb_Sorting_LIHC.png', error = FALSE)
```

-----

### Raw - Volcano Plot
```{r, echo=FALSE, out.width='75%', fig.align='left', fig.cap=''}
knitr::include_graphics('assets/RRA_QC/VolcanoPlot/31801065_MeghanHoldorf_CellRep_2019_HepG2.RG7834.Lo_HBsAb_Sorting_LIHC.png', error = FALSE)
```

-----

# 31801065 | MeghanHoldorf | CellRep | 2019 | HepG2.RG7834.Hi | HBsAg
## **Overview**
**PMID**: 31801065<br />
**Model**: HepG2 (human liver cancer cell line)<br />
**Treatment**: After CRISPR screen, HepG2 cells were treated with high dose RG7834 (30 nM) and then sorted with high Hepatitis B surface antigen (HBsAg) expression level<br />
**Control**: Sorted with low HBsAg expression level<br />
**Type**: Sorting<br />
**Description**: CRISPR screen in human liver cancer cells HepG2 and sorted with HBsAg high vs. HBsAg low conditions. Negative LFC values indicate genes whose knockout can decrease HBsAg protein expression level in the presense of high dose RG7834<br />

## **Original Figures**
```{r, echo=FALSE, out.width='85%', fig.align='left', fig.cap=''}
knitr::include_graphics("assets/original_fig/31801065_MeghanHoldorf_CellRep_2019_HepG2.RG7834.Hi_HBsAg_table.png", error = FALSE)
```

-----

## **MAGeCK-VISPR Results** {.tabset}
### Processed - Rank Plot
```{r, echo=FALSE, out.width='75%', fig.align='left', fig.cap=''}
knitr::include_graphics('assets/median_scaled_QC/RankPlot/31801065_MeghanHoldorf_CellRep_2019_HepG2.RG7834.Hi_HBsAg_Sorting_LIHC.png', error = FALSE)
```

-----

### Raw - Rank Plot
```{r, echo=FALSE, out.width='75%', fig.align='left', fig.cap=''}
knitr::include_graphics('assets/RRA_QC/RankPlot/31801065_MeghanHoldorf_CellRep_2019_HepG2.RG7834.Hi_HBsAb_Sorting_LIHC.png', error = FALSE)
```

-----

### Raw - Volcano Plot
```{r, echo=FALSE, out.width='75%', fig.align='left', fig.cap=''}
knitr::include_graphics('assets/RRA_QC/VolcanoPlot/31801065_MeghanHoldorf_CellRep_2019_HepG2.RG7834.Hi_HBsAb_Sorting_LIHC.png', error = FALSE)
```

-----

# 31919360 | NirHacohen | NatCommun | 2020 | A549.PR8 | IAV.HA
## **Overview**
**PMID**: 31919360<br />
**Model**: A549 (non-small cell lung cancer cell line)<br />
**Treatment**: After CRISPR screen, A549 cells were infected with influenza A/PR8 virus and then sorted with high influenza A virus hemagglutinin (IAV.HA) expression level<br />
**Control**: Sorted with low IAV.HA expression level<br />
**Type**: Sorting<br />
**Description**: CRISPR screen in human non-small cell lung cancer cells A549 and sorted with IAV.HA high vs. IAV.HA low conditions. Negative LFC values indicate genes whose knockout can decrease IAV.HA protein expression level<br />

## **Original Figures**
```{r, echo=FALSE, out.width='50%', fig.align='left', fig.cap=''}
knitr::include_graphics("assets/original_fig/31919360_NirHacohen_NatCommun_2020_A549_IAV.HA_overview.png", error = FALSE)
```
```{r, echo=FALSE, out.width='105%', fig.align='left', fig.cap=''}
knitr::include_graphics("assets/original_fig/31919360_NirHacohen_NatCommun_2020_A549_IAV.HA_primary.png", error = FALSE)
knitr::include_graphics("assets/original_fig/31919360_NirHacohen_NatCommun_2020_A549_IAV.HA_secondary.png", error = FALSE)
```

-----

## **MAGeCK-VISPR Results** {.tabset}
### Processed - Rank Plot
```{r, echo=FALSE, out.width='75%', fig.align='left', fig.cap=''}
knitr::include_graphics('assets/median_scaled_QC/RankPlot/31919360_NirHacohen_NatCommun_2020_A549_IAV.HA_Sorting_NSCLC.png', error = FALSE)
```

-----

### Raw - Rank Plot
```{r, echo=FALSE, out.width='75%', fig.align='left', fig.cap=''}
knitr::include_graphics('assets/RRA_QC/RankPlot/31919360_NirHacohen_NatCommun_2020_A549_IAV.HA_Sorting_NSCLC.png', error = FALSE)
```

-----

### Raw - Volcano Plot
```{r, echo=FALSE, out.width='75%', fig.align='left', fig.cap=''}
knitr::include_graphics('assets/RRA_QC/VolcanoPlot/31919360_NirHacohen_NatCommun_2020_A549_IAV.HA_Sorting_NSCLC.png', error = FALSE)
```

-----

# 32156810 | MichaelSDiamond | mBio | 2020 | BV2 | Bst2.High
## **Overview**
**PMID**: 32156810<br />
**Model**: BV2 (murine microglial cell)<br />
**Treatment**: After CRISPR screen, BV2 cells were treated with interferon beta (IFNb) and then sorted with  high tetherin (Bst2/CD317) expression level<br />
**Control**: Unsorted population<br />
**Type**: Sorting<br />
**Description**: CRISPR screen in mouse microglial cells BV2 followed by IFNb treatment and sorted with Bst2 high vs. unsorted population. Positive LFC values indicate genes whose knockout can increase Bst2 protein expression level<br />

## **Original Figures**
```{r, echo=FALSE, out.width='60%', fig.align='left', fig.cap=''}
knitr::include_graphics("assets/original_fig/32156810_MichaelSDiamond_mBio_2020_BV2_Bst2.High_overview.png", error = FALSE)
```
```{r, echo=FALSE, out.width='85%', fig.align='left', fig.cap=''}
knitr::include_graphics("assets/original_fig/32156810_MichaelSDiamond_mBio_2020_BV2_Bst2.High_lib1.png", error = FALSE)
knitr::include_graphics("assets/original_fig/32156810_MichaelSDiamond_mBio_2020_BV2_Bst2.High_lib5.png", error = FALSE)
```

-----

## **MAGeCK-VISPR Results** {.tabset}
### Processed - Rank Plot
```{r, echo=FALSE, out.width='75%', fig.align='left', fig.cap=''}
knitr::include_graphics('assets/median_scaled_QC/RankPlot/32156810_MichaelSDiamond_mBio_2020_BV2_Bst2.High_Sorting_Microglial.png', error = FALSE)
```

-----

### Raw - Rank Plot
```{r, echo=FALSE, out.width='75%', fig.align='left', fig.cap=''}
knitr::include_graphics('assets/RRA_QC/RankPlot/32156810_MichaelSDiamond_mBio_2020_BV2_Bst2.High_L1_Sorting_Microglial.png', error = FALSE)
knitr::include_graphics('assets/RRA_QC/RankPlot/32156810_MichaelSDiamond_mBio_2020_BV2_Bst2.High_L5_Sorting_Microglial.png', error = FALSE)
```

-----

### Raw - Volcano Plot
```{r, echo=FALSE, out.width='75%', fig.align='left', fig.cap=''}
knitr::include_graphics('assets/RRA_QC/VolcanoPlot/32156810_MichaelSDiamond_mBio_2020_BV2_Bst2.High_L1_Sorting_Microglial.png', error = FALSE)
knitr::include_graphics('assets/RRA_QC/VolcanoPlot/32156810_MichaelSDiamond_mBio_2020_BV2_Bst2.High_L5_Sorting_Microglial.png', error = FALSE)
```

-----

# 32499641 | DeyuFang | Nature | 2020 | Treg | Foxp3
## **Overview**
**PMID**: 32499641<br />
**Model**: Treg (murine regulatory T cells)<br />
**Treatment**: After CRISPR screen, Treg cells were sorted with high Foxp3 expression level<br />
**Control**: Sorted with low Foxp3 expression level<br />
**Type**: Sorting<br />
**Description**: CRISPR screen in mouse regulatory T cells and sorted with Foxp3 high vs. low conditions Positive LFC values indicate genes whose knockout can increase Foxp3 protein expression level<br />

## **Original Figures**
```{r, echo=FALSE, out.width='70%', fig.align='left', fig.cap=''}
knitr::include_graphics("assets/original_fig/32499641_DeyuFang_Nature_2020_Treg_Foxp3_overview.png", error = FALSE)
```
```{r, echo=FALSE, out.width='85%', fig.align='left', fig.cap=''}
knitr::include_graphics("assets/original_fig/32499641_DeyuFang_Nature_2020_Treg_Foxp3.png", error = FALSE)
```

-----

## **MAGeCK-VISPR Results** {.tabset}
### Processed - Rank Plot
```{r, echo=FALSE, out.width='75%', fig.align='left', fig.cap=''}
knitr::include_graphics('assets/median_scaled_QC/RankPlot/32499641_DeyuFang_Nature_2020_Treg_Foxp3_Sorting_T-cell.png', error = FALSE)
```

-----

### Raw - Rank Plot
```{r, echo=FALSE, out.width='75%', fig.align='left', fig.cap=''}
knitr::include_graphics('assets/RRA_QC/RankPlot/32499641_DeyuFang_Nature_2020_Treg_Foxp3_Sorting_T-cell.png', error = FALSE)
```

-----

### Raw - Volcano Plot
```{r, echo=FALSE, out.width='75%', fig.align='left', fig.cap=''}
knitr::include_graphics('assets/RRA_QC/VolcanoPlot/32499641_DeyuFang_Nature_2020_Treg_Foxp3_Sorting_T-cell.png', error = FALSE)
```

-----

# 33271120 | JonathanWYewdell | Immunity | 2021 | BJAB | MHCI
## **Overview**
**PMID**: 33271120<br />
**Model**: BJAB (human diffuse large B-cell lymphoma, DLBCL)<br />
**Treatment**: After CRISPR screen, BJAB cells were sorted two rounds with high level MHC-I-specific W6/32 antibody<br />
**Control**: Sorted with low level MHC-I-specific antibody<br />
**Type**: Sorting<br />
**Description**: CRISPR screen in human diffuse large B-cell lymphoma (DLBCL) BJAB cells and sorted with MHC-I high vs. MHC-I low conditions. Positive LFC values indicate genes whose knockout can increase MHC-I protein expression level<br />

## **Original Figures**
```{r, echo=FALSE, out.width='55%', fig.align='left', fig.cap=''}
knitr::include_graphics("assets/original_fig/33271120_JonathanWYewdell_Immunity_2021_BJAB_MHCI.png", error = FALSE)
```

-----

## **MAGeCK-VISPR Results** {.tabset}
### Processed - Rank Plot
```{r, echo=FALSE, out.width='75%', fig.align='left', fig.cap=''}
knitr::include_graphics('assets/median_scaled_QC/RankPlot/33271120_JonathanWYewdell_Immunity_2021_BJAB_MHCI_Sorting_DLBCL.png', error = FALSE)
```

-----

### Raw - Rank Plot
```{r, echo=FALSE, out.width='75%', fig.align='left', fig.cap=''}
knitr::include_graphics('assets/RRA_QC/RankPlot/33271120_JonathanWYewdell_Immunity_2021_BJAB_MHCI_r1_Sorting_DLBCL.png', error = FALSE)
knitr::include_graphics('assets/RRA_QC/RankPlot/33271120_JonathanWYewdell_Immunity_2021_BJAB_MHCI_r2_Sorting_DLBCL.png', error = FALSE)
```

-----

### Raw - Volcano Plot
```{r, echo=FALSE, out.width='75%', fig.align='left', fig.cap=''}
knitr::include_graphics('assets/RRA_QC/VolcanoPlot/33271120_JonathanWYewdell_Immunity_2021_BJAB_MHCI_r1_Sorting_DLBCL.png', error = FALSE)
knitr::include_graphics('assets/RRA_QC/VolcanoPlot/33271120_JonathanWYewdell_Immunity_2021_BJAB_MHCI_r2_Sorting_DLBCL.png', error = FALSE)
```

-----

# 33271120 | JonathanWYewdell | Immunity | 2021 | HBL1 | MHCI
## **Overview**
**PMID**: 33271120<br />
**Model**: HBL1 (human diffuse large B-cell lymphoma, DLBCL)<br />
**Treatment**: After CRISPR screen, HBL1 cells were sorted two rounds with high level MHC-I-specific W6/32 antibody<br />
**Control**: Sorted with low level MHC-I-specific antibody<br />
**Type**: Sorting<br />
**Description**: CRISPR screen in human diffuse large B-cell lymphoma (DLBCL) HBL1 cells and sorted with MHC-I high vs. MHC-I low conditions. Positive LFC values indicate genes whose knockout can increase MHC-I protein expression level<br />

## **Original Figures**
```{r, echo=FALSE, out.width='55%', fig.align='left', fig.cap=''}
knitr::include_graphics("assets/original_fig/33271120_JonathanWYewdell_Immunity_2021_HBL1_MHCI.png", error = FALSE)
```

-----

## **MAGeCK-VISPR Results** {.tabset}
### Processed - Rank Plot
```{r, echo=FALSE, out.width='75%', fig.align='left', fig.cap=''}
knitr::include_graphics('assets/median_scaled_QC/RankPlot/33271120_JonathanWYewdell_Immunity_2021_HBL1_MHCI_Sorting_DLBCL.png', error = FALSE)
```

-----

### Raw - Rank Plot
```{r, echo=FALSE, out.width='75%', fig.align='left', fig.cap=''}
knitr::include_graphics('assets/RRA_QC/RankPlot/33271120_JonathanWYewdell_Immunity_2021_HBL1_MHCI_r1_Sorting_DLBCL.png', error = FALSE)
knitr::include_graphics('assets/RRA_QC/RankPlot/33271120_JonathanWYewdell_Immunity_2021_HBL1_MHCI_r2_Sorting_DLBCL.png', error = FALSE)
```

-----

### Raw - Volcano Plot
```{r, echo=FALSE, out.width='75%', fig.align='left', fig.cap=''}
knitr::include_graphics('assets/RRA_QC/VolcanoPlot/33271120_JonathanWYewdell_Immunity_2021_HBL1_MHCI_r1_Sorting_DLBCL.png', error = FALSE)
knitr::include_graphics('assets/RRA_QC/VolcanoPlot/33271120_JonathanWYewdell_Immunity_2021_HBL1_MHCI_r2_Sorting_DLBCL.png', error = FALSE)
```

-----

# 33271120 | JonathanWYewdell | Immunity | 2021 | SUDHL5 | MHCI
## **Overview**
**PMID**: 33271120<br />
**Model**: SUDHL5 (human diffuse large B-cell lymphoma, DLBCL)<br />
**Treatment**: After CRISPR screen, BJAB cells were sorted two rounds with high level MHC-I-specific W6/32 antibody<br />
**Control**: Sorted with low level MHC-I-specific antibody<br />
**Type**: Sorting<br />
**Description**: CRISPR screen in human diffuse large B-cell lymphoma (DLBCL) SUDHL5 cells and sorted with MHC-I high vs. MHC-I low conditions. Positive LFC values indicate genes whose knockout can increase MHC-I protein expression level<br />

## **Original Figures**
```{r, echo=FALSE, out.width='55%', fig.align='left', fig.cap=''}
knitr::include_graphics("assets/original_fig/33271120_JonathanWYewdell_Immunity_2021_SUDHL5_MHCI.png", error = FALSE)
```

-----

## **MAGeCK-VISPR Results** {.tabset}
### Processed - Rank Plot
```{r, echo=FALSE, out.width='75%', fig.align='left', fig.cap=''}
knitr::include_graphics('assets/median_scaled_QC/RankPlot/33271120_JonathanWYewdell_Immunity_2021_SUDHL5_MHCI_Sorting_DLBCL.png', error = FALSE)
```

-----

### Raw - Rank Plot
```{r, echo=FALSE, out.width='75%', fig.align='left', fig.cap=''}
knitr::include_graphics('assets/RRA_QC/RankPlot/33271120_JonathanWYewdell_Immunity_2021_SUDHL5_MHCI_r1_Sorting_DLBCL.png', error = FALSE)
knitr::include_graphics('assets/RRA_QC/RankPlot/33271120_JonathanWYewdell_Immunity_2021_SUDHL5_MHCI_r2_Sorting_DLBCL.png', error = FALSE)
```

-----

### Raw - Volcano Plot
```{r, echo=FALSE, out.width='75%', fig.align='left', fig.cap=''}
knitr::include_graphics('assets/RRA_QC/VolcanoPlot/33271120_JonathanWYewdell_Immunity_2021_SUDHL5_MHCI_r1_Sorting_DLBCL.png', error = FALSE)
knitr::include_graphics('assets/RRA_QC/VolcanoPlot/33271120_JonathanWYewdell_Immunity_2021_SUDHL5_MHCI_r2_Sorting_DLBCL.png', error = FALSE)
```

-----

# 33271120 | JonathanWYewdell | Immunity | 2021 | TMD8 | MHCI
## **Overview**
**PMID**: 33271120<br />
**Model**: TMD8 (human diffuse large B-cell lymphoma, DLBCL)<br />
**Treatment**: After CRISPR screen, BJAB cells were sorted two rounds with high level MHC-I-specific W6/32 antibody<br />
**Control**: Sorted with low level MHC-I-specific antibody<br />
**Type**: Sorting<br />
**Description**: CRISPR screen in human diffuse large B-cell lymphoma (DLBCL) TMD8 cells and sorted with MHC-I high vs. MHC-I low conditions. Positive LFC values indicate genes whose knockout can increase MHC-I protein expression level<br />

## **Original Figures**
```{r, echo=FALSE, out.width='55%', fig.align='left', fig.cap=''}
knitr::include_graphics("assets/original_fig/33271120_JonathanWYewdell_Immunity_2021_TMD8_MHCI.png", error = FALSE)
```

-----

## **MAGeCK-VISPR Results** {.tabset}
### Processed - Rank Plot
```{r, echo=FALSE, out.width='75%', fig.align='left', fig.cap=''}
knitr::include_graphics('assets/median_scaled_QC/RankPlot/33271120_JonathanWYewdell_Immunity_2021_TMD8_MHCI_Sorting_DLBCL.png', error = FALSE)
```

-----

### Raw - Rank Plot
```{r, echo=FALSE, out.width='75%', fig.align='left', fig.cap=''}
knitr::include_graphics('assets/RRA_QC/RankPlot/33271120_JonathanWYewdell_Immunity_2021_TMD8_MHCI_r1_Sorting_DLBCL.png', error = FALSE)
knitr::include_graphics('assets/RRA_QC/RankPlot/33271120_JonathanWYewdell_Immunity_2021_TMD8_MHCI_r2_Sorting_DLBCL.png', error = FALSE)
```

-----

### Raw - Volcano Plot
```{r, echo=FALSE, out.width='75%', fig.align='left', fig.cap=''}
knitr::include_graphics('assets/RRA_QC/VolcanoPlot/33271120_JonathanWYewdell_Immunity_2021_TMD8_MHCI_r1_Sorting_DLBCL.png', error = FALSE)
knitr::include_graphics('assets/RRA_QC/VolcanoPlot/33271120_JonathanWYewdell_Immunity_2021_TMD8_MHCI_r2_Sorting_DLBCL.png', error = FALSE)
```

-----

# 33589424 | XShirleyLiu | CancerDiscov | 2021 |  B16F10 | M1.negScreen.MHCI.high
## **Overview**
**PMID**: 33589424<br />
**Model**: B16F10 (murine skin melanoma cell line)<br />
**Treatment**: Negative regulators screens. B16F10 cells was pretreated with 0.1ng/ml IFNγ (low dose) followed by CRISPR screen using M1 library, and then sorted with MHC-I.high condition<br />
**Control**: Unsorted population<br />
**Type**: Sorting<br />
**Description**: CRISPR screen in mouse B16F10 cells pretreated with low dose IFNγ and sorted with MHC-I.high vs. unsorted condition. Positive LFC values indicate genes whose knockout can increase MHC-I associated proteins expression levels<br />

## **Original Figures**
```{r, echo=FALSE, out.width='100%', fig.align='left', fig.cap=''}
knitr::include_graphics("assets/original_fig/33589424_XShirleyLiu_CancerDiscov_2021_overview.png", error = FALSE)
```
```{r, echo=FALSE, out.width='35%', fig.align='left', fig.cap=''}
knitr::include_graphics("assets/original_fig/33589424_XShirleyLiu_CancerDiscov_2021_B16F10_negScreen.MHCI.high_Sorting_SKCM.png", error = FALSE)
```
```{r, echo=FALSE, out.width='70%', fig.align='left', fig.cap=''}
knitr::include_graphics("assets/original_fig/33589424_XShirleyLiu_CancerDiscov_2021_B16F10_negScreen.MHCI.high_Sorting_SKCM.table.png", error = FALSE)
```

-----

## **MAGeCK-VISPR Results** {.tabset}
### Processed - Rank Plot
```{r, echo=FALSE, out.width='75%', fig.align='left', fig.cap=''}
knitr::include_graphics('assets/median_scaled_QC/RankPlot/33589424_XShirleyLiu_CancerDiscov_2021_B16F10_M1.negScreen.MHCI.high_Sorting_SKCM.png', error = FALSE)
```

-----

### Raw - Rank Plot
```{r, echo=FALSE, out.width='75%', fig.align='left', fig.cap=''}
knitr::include_graphics('assets/RRA_QC/RankPlot/33589424_XShirleyLiu_CancerDiscov_2021_B16F10_M1.negScreen.MHCI.high_Sorting_SKCM.png', error = FALSE)
```

-----

### Raw - Volcano Plot
```{r, echo=FALSE, out.width='75%', fig.align='left', fig.cap=''}
knitr::include_graphics('assets/RRA_QC/VolcanoPlot/33589424_XShirleyLiu_CancerDiscov_2021_B16F10_M1.negScreen.MHCI.high_Sorting_SKCM.png', error = FALSE)
```

-----

# 33589424 | XShirleyLiu | CancerDiscov | 2021 |  B16F10 | M2.negScreen.MHCI.high
## **Overview**
**PMID**: 33589424<br />
**Model**: B16F10 (murine skin melanoma cell line)<br />
**Treatment**: Negative regulators screens. B16F10 cells was pretreated with 0.1ng/ml IFNγ (low dose) followed by CRISPR screen using M2 library, and then sorted with MHC-I.high condition<br />
**Control**: Unsorted population<br />
**Type**: Sorting<br />
**Description**: CRISPR screen in mouse B16F10 cells pretreated with low dose IFNγ and sorted with MHC-I.high vs. unsorted condition. Positive LFC values indicate genes whose knockout can increase MHC-I associated proteins expression levels<br />

## **Original Figures**
```{r, echo=FALSE, out.width='100%', fig.align='left', fig.cap=''}
knitr::include_graphics("assets/original_fig/33589424_XShirleyLiu_CancerDiscov_2021_overview.png", error = FALSE)
```
```{r, echo=FALSE, out.width='35%', fig.align='left', fig.cap=''}
knitr::include_graphics("assets/original_fig/33589424_XShirleyLiu_CancerDiscov_2021_B16F10_negScreen.MHCI.high_Sorting_SKCM.png", error = FALSE)
```
```{r, echo=FALSE, out.width='70%', fig.align='left', fig.cap=''}
knitr::include_graphics("assets/original_fig/33589424_XShirleyLiu_CancerDiscov_2021_B16F10_negScreen.MHCI.high_Sorting_SKCM.table.png", error = FALSE)
```

-----

## **MAGeCK-VISPR Results** {.tabset}
### Processed - Rank Plot
```{r, echo=FALSE, out.width='75%', fig.align='left', fig.cap=''}
knitr::include_graphics('assets/median_scaled_QC/RankPlot/33589424_XShirleyLiu_CancerDiscov_2021_B16F10_M2.negScreen.MHCI.high_Sorting_SKCM.png', error = FALSE)
```

-----

### Raw - Rank Plot
```{r, echo=FALSE, out.width='75%', fig.align='left', fig.cap=''}
knitr::include_graphics('assets/RRA_QC/RankPlot/33589424_XShirleyLiu_CancerDiscov_2021_B16F10_M2.negScreen.MHCI.high_Sorting_SKCM.png', error = FALSE)
```

-----

### Raw - Volcano Plot
```{r, echo=FALSE, out.width='75%', fig.align='left', fig.cap=''}
knitr::include_graphics('assets/RRA_QC/VolcanoPlot/33589424_XShirleyLiu_CancerDiscov_2021_B16F10_M2.negScreen.MHCI.high_Sorting_SKCM.png', error = FALSE)
```

-----

# 33589424 | XShirleyLiu | CancerDiscov | 2021 |  B16F10 | M1.negScreen.MHCI.high+PDL1.high
## **Overview**
**PMID**: 33589424<br />
**Model**: B16F10 (murine skin melanoma cell line)<br />
**Treatment**: Negative regulators screens. B16F10 cells was pretreated with 0.1ng/ml IFNγ (low dose) followed by CRISPR screen using M1 library, and then sorted with MHC-I.high+PD-L1.high condition<br />
**Control**: Unsorted population<br />
**Type**: Sorting<br />
**Description**: CRISPR screen in mouse B16F10 cells pretreated with low dose IFNγ and sorted with MHC-I.high+PD-L1.high vs. unsorted condition. Positive LFC values indicate genes whose knockout can increase both MHC-I associated proteins and PD-L1 protein expression levels<br />

## **Original Figures**
```{r, echo=FALSE, out.width='100%', fig.align='left', fig.cap=''}
knitr::include_graphics("assets/original_fig/33589424_XShirleyLiu_CancerDiscov_2021_overview.png", error = FALSE)
```
```{r, echo=FALSE, out.width='35%', fig.align='left', fig.cap=''}
knitr::include_graphics("assets/original_fig/33589424_XShirleyLiu_CancerDiscov_2021_B16F10_negScreen.MHCI.high+PDL1.high_Sorting_SKCM.png", error = FALSE)
```
```{r, echo=FALSE, out.width='70%', fig.align='left', fig.cap=''}
knitr::include_graphics("assets/original_fig/33589424_XShirleyLiu_CancerDiscov_2021_B16F10_negScreen.MHCI.high+PDL1.high_Sorting_SKCM.table.png", error = FALSE)
```

-----

## **MAGeCK-VISPR Results** {.tabset}
### Processed - Rank Plot
```{r, echo=FALSE, out.width='75%', fig.align='left', fig.cap=''}
knitr::include_graphics('assets/median_scaled_QC/RankPlot/33589424_XShirleyLiu_CancerDiscov_2021_B16F10_M1.negScreen.MHCI.high+PDL1.high_Sorting_SKCM.png', error = FALSE)
```

-----

### Raw - Rank Plot
```{r, echo=FALSE, out.width='75%', fig.align='left', fig.cap=''}
knitr::include_graphics('assets/RRA_QC/RankPlot/33589424_XShirleyLiu_CancerDiscov_2021_B16F10_M1.negScreen.MHCI.high+PDL1.high_Sorting_SKCM.png', error = FALSE)
```

-----

### Raw - Volcano Plot
```{r, echo=FALSE, out.width='75%', fig.align='left', fig.cap=''}
knitr::include_graphics('assets/RRA_QC/VolcanoPlot/33589424_XShirleyLiu_CancerDiscov_2021_B16F10_M1.negScreen.MHCI.high+PDL1.high_Sorting_SKCM.png', error = FALSE)
```

-----

# 33589424 | XShirleyLiu | CancerDiscov | 2021 |  B16F10 | M2.negScreen.MHCI.high+PDL1.high
## **Overview**
**PMID**: 33589424<br />
**Model**: B16F10 (murine skin melanoma cell line)<br />
**Treatment**: Negative regulators screens. B16F10 cells was pretreated with 0.1ng/ml IFNγ (low dose) followed by CRISPR screen using M2 library, and then sorted with MHC-I.high+PD-L1.high condition<br />
**Control**: Unsorted population<br />
**Type**: Sorting<br />
**Description**: CRISPR screen in mouse B16F10 cells pretreated with low dose IFNγ and sorted with MHC-I.high+PD-L1.high vs. unsorted condition. Positive LFC values indicate genes whose knockout can increase both MHC-I associated proteins and PD-L1 protein expression levels<br />

## **Original Figures**
```{r, echo=FALSE, out.width='100%', fig.align='left', fig.cap=''}
knitr::include_graphics("assets/original_fig/33589424_XShirleyLiu_CancerDiscov_2021_overview.png", error = FALSE)
```
```{r, echo=FALSE, out.width='35%', fig.align='left', fig.cap=''}
knitr::include_graphics("assets/original_fig/33589424_XShirleyLiu_CancerDiscov_2021_B16F10_negScreen.MHCI.high+PDL1.high_Sorting_SKCM.png", error = FALSE)
```
```{r, echo=FALSE, out.width='70%', fig.align='left', fig.cap=''}
knitr::include_graphics("assets/original_fig/33589424_XShirleyLiu_CancerDiscov_2021_B16F10_negScreen.MHCI.high+PDL1.high_Sorting_SKCM.table.png", error = FALSE)
```

-----

## **MAGeCK-VISPR Results** {.tabset}
### Processed - Rank Plot
```{r, echo=FALSE, out.width='75%', fig.align='left', fig.cap=''}
knitr::include_graphics('assets/median_scaled_QC/RankPlot/33589424_XShirleyLiu_CancerDiscov_2021_B16F10_M2.negScreen.MHCI.high+PDL1.high_Sorting_SKCM.png', error = FALSE)
```

-----

### Raw - Rank Plot
```{r, echo=FALSE, out.width='75%', fig.align='left', fig.cap=''}
knitr::include_graphics('assets/RRA_QC/RankPlot/33589424_XShirleyLiu_CancerDiscov_2021_B16F10_M2.negScreen.MHCI.high+PDL1.high_Sorting_SKCM.png', error = FALSE)
```

-----

### Raw - Volcano Plot
```{r, echo=FALSE, out.width='75%', fig.align='left', fig.cap=''}
knitr::include_graphics('assets/RRA_QC/VolcanoPlot/33589424_XShirleyLiu_CancerDiscov_2021_B16F10_M2.negScreen.MHCI.high+PDL1.high_Sorting_SKCM.png', error = FALSE)
```

-----

# 33589424 | XShirleyLiu | CancerDiscov | 2021 |  B16F10 | M1.negScreen.PDL1.high
## **Overview**
**PMID**: 33589424<br />
**Model**: B16F10 (murine skin melanoma cell line)<br />
**Treatment**: Negative regulators screens. B16F10 cells was pretreated with 0.1ng/ml IFNγ (low dose) followed by CRISPR screen using M1 library, and then sorted with PD-L1.high condition<br />
**Control**: Unsorted population<br />
**Type**: Sorting<br />
**Description**: CRISPR screen in mouse B16F10 cells pretreated with low dose IFNγ and sorted with PD-L1.high vs. unsorted condition. Positive LFC values indicate genes whose knockout can increase PD-L1 protein expression level<br />

## **Original Figures**
```{r, echo=FALSE, out.width='100%', fig.align='left', fig.cap=''}
knitr::include_graphics("assets/original_fig/33589424_XShirleyLiu_CancerDiscov_2021_overview.png", error = FALSE)
```
```{r, echo=FALSE, out.width='70%', fig.align='left', fig.cap=''}
knitr::include_graphics("assets/original_fig/33589424_XShirleyLiu_CancerDiscov_2021_B16F10_negScreen.PDL1.high_Sorting_SKCM.table.png", error = FALSE)
```

-----

## **MAGeCK-VISPR Results** {.tabset}
### Processed - Rank Plot
```{r, echo=FALSE, out.width='75%', fig.align='left', fig.cap=''}
knitr::include_graphics('assets/median_scaled_QC/RankPlot/33589424_XShirleyLiu_CancerDiscov_2021_B16F10_M1.negScreen.PDL1.high_Sorting_SKCM.png', error = FALSE)
```

-----

### Raw - Rank Plot
```{r, echo=FALSE, out.width='75%', fig.align='left', fig.cap=''}
knitr::include_graphics('assets/RRA_QC/RankPlot/33589424_XShirleyLiu_CancerDiscov_2021_B16F10_M1.negScreen.PDL1.high_Sorting_SKCM.png', error = FALSE)
```

-----

### Raw - Volcano Plot
```{r, echo=FALSE, out.width='75%', fig.align='left', fig.cap=''}
knitr::include_graphics('assets/RRA_QC/VolcanoPlot/33589424_XShirleyLiu_CancerDiscov_2021_B16F10_M1.negScreen.PDL1.high_Sorting_SKCM.png', error = FALSE)
```

-----

# 33589424 | XShirleyLiu | CancerDiscov | 2021 |  B16F10 | M2.negScreen.PDL1.high
## **Overview**
**PMID**: 33589424<br />
**Model**: B16F10 (murine skin melanoma cell line)<br />
**Treatment**: Negative regulators screens. B16F10 cells was pretreated with 0.1ng/ml IFNγ (low dose) followed by CRISPR screen using M2 library, and then sorted with PD-L1.high condition<br />
**Control**: Unsorted population<br />
**Type**: Sorting<br />
**Description**: CRISPR screen in mouse B16F10 cells pretreated with low dose IFNγ and sorted with PD-L1.high vs. unsorted condition. Positive LFC values indicate genes whose knockout can increase PD-L1 protein expression level<br />

## **Original Figures**
```{r, echo=FALSE, out.width='100%', fig.align='left', fig.cap=''}
knitr::include_graphics("assets/original_fig/33589424_XShirleyLiu_CancerDiscov_2021_overview.png", error = FALSE)
```
```{r, echo=FALSE, out.width='70%', fig.align='left', fig.cap=''}
knitr::include_graphics("assets/original_fig/33589424_XShirleyLiu_CancerDiscov_2021_B16F10_negScreen.PDL1.high_Sorting_SKCM.table.png", error = FALSE)
```

-----

## **MAGeCK-VISPR Results** {.tabset}
### Processed - Rank Plot
```{r, echo=FALSE, out.width='75%', fig.align='left', fig.cap=''}
knitr::include_graphics('assets/median_scaled_QC/RankPlot/33589424_XShirleyLiu_CancerDiscov_2021_B16F10_M2.negScreen.PDL1.high_Sorting_SKCM.png', error = FALSE)
```

-----

### Raw - Rank Plot
```{r, echo=FALSE, out.width='75%', fig.align='left', fig.cap=''}
knitr::include_graphics('assets/RRA_QC/RankPlot/33589424_XShirleyLiu_CancerDiscov_2021_B16F10_M2.negScreen.PDL1.high_Sorting_SKCM.png', error = FALSE)
```

-----

### Raw - Volcano Plot
```{r, echo=FALSE, out.width='75%', fig.align='left', fig.cap=''}
knitr::include_graphics('assets/RRA_QC/VolcanoPlot/33589424_XShirleyLiu_CancerDiscov_2021_B16F10_M2.negScreen.PDL1.high_Sorting_SKCM.png', error = FALSE)
```

-----

# 33589424 | XShirleyLiu | CancerDiscov | 2021 |  B16F10 | M1.posScreen.MHCI.low
## **Overview**
**PMID**: 33589424<br />
**Model**: B16F10 (murine skin melanoma cell line)<br />
**Treatment**: Positive regulators screens. B16F10 cells was pretreated with 10ng/ml IFNγ (high dose) followed by CRISPR screen using M1 library, and then sorted with MHC-I.low condition<br />
**Control**: Unsorted population<br />
**Type**: Sorting<br />
**Description**: CRISPR screen in mouse B16F10 cells pretreated with high dose IFNγ and sorted with MHC-I.low vs. unsorted condition. The sign of LFC values were then reversed so that negative LFC values indicate genes whose knockout can decrease MHC-I associated proteins expression levels<br />

## **Original Figures**
```{r, echo=FALSE, out.width='100%', fig.align='left', fig.cap=''}
knitr::include_graphics("assets/original_fig/33589424_XShirleyLiu_CancerDiscov_2021_overview.png", error = FALSE)
```
```{r, echo=FALSE, out.width='35%', fig.align='left', fig.cap=''}
knitr::include_graphics("assets/original_fig/33589424_XShirleyLiu_CancerDiscov_2021_B16F10_posScreen.MHCI.low_Sorting_SKCM.png", error = FALSE)
```
```{r, echo=FALSE, out.width='70%', fig.align='left', fig.cap=''}
knitr::include_graphics("assets/original_fig/33589424_XShirleyLiu_CancerDiscov_2021_B16F10_posScreen.MHCI.low_Sorting_SKCM.table.png", error = FALSE)
```

-----

## **MAGeCK-VISPR Results** {.tabset}
### Processed - Rank Plot
```{r, echo=FALSE, out.width='75%', fig.align='left', fig.cap=''}
knitr::include_graphics('assets/median_scaled_QC/RankPlot/33589424_XShirleyLiu_CancerDiscov_2021_B16F10_M1.posScreen.MHCI.low_Sorting_SKCM.png', error = FALSE)
```

-----

### Raw - Rank Plot
```{r, echo=FALSE, out.width='75%', fig.align='left', fig.cap=''}
knitr::include_graphics('assets/RRA_QC/RankPlot/33589424_XShirleyLiu_CancerDiscov_2021_B16F10_M1.posScreen.MHCI.low_Sorting_SKCM.png', error = FALSE)
```

-----

### Raw - Volcano Plot
```{r, echo=FALSE, out.width='75%', fig.align='left', fig.cap=''}
knitr::include_graphics('assets/RRA_QC/VolcanoPlot/33589424_XShirleyLiu_CancerDiscov_2021_B16F10_M1.posScreen.MHCI.low_Sorting_SKCM.png', error = FALSE)
```

-----

# 33589424 | XShirleyLiu | CancerDiscov | 2021 |  B16F10 | M2.posScreen.MHCI.low
## **Overview**
**PMID**: 33589424<br />
**Model**: B16F10 (murine skin melanoma cell line)<br />
**Treatment**: Positive regulators screens. B16F10 cells was pretreated with 10ng/ml IFNγ (high dose) followed by CRISPR screen using M2 library, and then sorted with MHC-I.low condition<br />
**Control**: Unsorted population<br />
**Type**: Sorting<br />
**Description**: CRISPR screen in mouse B16F10 cells pretreated with high dose IFNγ and sorted with MHC-I.low vs. unsorted condition. The sign of LFC values were then reversed so that negative LFC values indicate genes whose knockout can decrease MHC-I associated proteins expression levels<br />

## **Original Figures**
```{r, echo=FALSE, out.width='100%', fig.align='left', fig.cap=''}
knitr::include_graphics("assets/original_fig/33589424_XShirleyLiu_CancerDiscov_2021_overview.png", error = FALSE)
```
```{r, echo=FALSE, out.width='35%', fig.align='left', fig.cap=''}
knitr::include_graphics("assets/original_fig/33589424_XShirleyLiu_CancerDiscov_2021_B16F10_posScreen.MHCI.low_Sorting_SKCM.png", error = FALSE)
```
```{r, echo=FALSE, out.width='70%', fig.align='left', fig.cap=''}
knitr::include_graphics("assets/original_fig/33589424_XShirleyLiu_CancerDiscov_2021_B16F10_posScreen.MHCI.low_Sorting_SKCM.table.png", error = FALSE)
```

-----

## **MAGeCK-VISPR Results** {.tabset}
### Processed - Rank Plot
```{r, echo=FALSE, out.width='75%', fig.align='left', fig.cap=''}
knitr::include_graphics('assets/median_scaled_QC/RankPlot/33589424_XShirleyLiu_CancerDiscov_2021_B16F10_M2.posScreen.MHCI.low_Sorting_SKCM.png', error = FALSE)
```

-----

### Raw - Rank Plot
```{r, echo=FALSE, out.width='75%', fig.align='left', fig.cap=''}
knitr::include_graphics('assets/RRA_QC/RankPlot/33589424_XShirleyLiu_CancerDiscov_2021_B16F10_M2.posScreen.MHCI.low_Sorting_SKCM.png', error = FALSE)
```

-----

### Raw - Volcano Plot
```{r, echo=FALSE, out.width='75%', fig.align='left', fig.cap=''}
knitr::include_graphics('assets/RRA_QC/VolcanoPlot/33589424_XShirleyLiu_CancerDiscov_2021_B16F10_M2.posScreen.MHCI.low_Sorting_SKCM.png', error = FALSE)
```

-----

# 33589424 | XShirleyLiu | CancerDiscov | 2021 |  B16F10 | M1.posScreen.MHCI.low+PDL1.low
## **Overview**
**PMID**: 33589424<br />
**Model**: B16F10 (murine skin melanoma cell line)<br />
**Treatment**: Positive regulators screens. B16F10 cells was pretreated with 10ng/ml IFNγ (high dose) followed by CRISPR screen using M1 library, and then sorted with MHCI.low+PDL1.low condition<br />
**Control**: Unsorted population<br />
**Type**: Sorting<br />
**Description**: CRISPR screen in mouse B16F10 cells pretreated with high dose IFNγ and sorted withMHCI.low+PDL1.low vs. unsorted condition. The sign of LFC values were then reversed so that negative LFC values indicate genes whose knockout can decrease both MHC-I associated proteins and PD-L1 protein expression levels<br />

## **Original Figures**
```{r, echo=FALSE, out.width='100%', fig.align='left', fig.cap=''}
knitr::include_graphics("assets/original_fig/33589424_XShirleyLiu_CancerDiscov_2021_overview.png", error = FALSE)
```
```{r, echo=FALSE, out.width='35%', fig.align='left', fig.cap=''}
knitr::include_graphics("assets/original_fig/33589424_XShirleyLiu_CancerDiscov_2021_B16F10_posScreen.MHCI.low+PDL1.low_Sorting_SKCM.png", error = FALSE)
```
```{r, echo=FALSE, out.width='70%', fig.align='left', fig.cap=''}
knitr::include_graphics("assets/original_fig/33589424_XShirleyLiu_CancerDiscov_2021_B16F10_posScreen.MHCI.low+PDL1.low_Sorting_SKCM.table.png", error = FALSE)
```

-----

## **MAGeCK-VISPR Results** {.tabset}
### Processed - Rank Plot
```{r, echo=FALSE, out.width='75%', fig.align='left', fig.cap=''}
knitr::include_graphics('assets/median_scaled_QC/RankPlot/33589424_XShirleyLiu_CancerDiscov_2021_B16F10_M1.posScreen.MHCI.low+PDL1.low_Sorting_SKCM.png', error = FALSE)
```

-----

### Raw - Rank Plot
```{r, echo=FALSE, out.width='75%', fig.align='left', fig.cap=''}
knitr::include_graphics('assets/RRA_QC/RankPlot/33589424_XShirleyLiu_CancerDiscov_2021_B16F10_M1.posScreen.MHCI.low+PDL1.low_Sorting_SKCM.png', error = FALSE)
```

-----

### Raw - Volcano Plot
```{r, echo=FALSE, out.width='75%', fig.align='left', fig.cap=''}
knitr::include_graphics('assets/RRA_QC/VolcanoPlot/33589424_XShirleyLiu_CancerDiscov_2021_B16F10_M1.posScreen.MHCI.low+PDL1.low_Sorting_SKCM.png', error = FALSE)
```

-----

# 33589424 | XShirleyLiu | CancerDiscov | 2021 |  B16F10 | M2.posScreen.MHCI.low+PDL1.low
## **Overview**
**PMID**: 33589424<br />
**Model**: B16F10 (murine skin melanoma cell line)<br />
**Treatment**: Positive regulators screens. B16F10 cells was pretreated with 10ng/ml IFNγ (high dose) followed by CRISPR screen using M2 library, and then sorted with MHCI.low+PDL1.low condition<br />
**Control**: Unsorted population<br />
**Type**: Sorting<br />
**Description**: CRISPR screen in mouse B16F10 cells pretreated with high dose IFNγ and sorted withMHCI.low+PDL1.low vs. unsorted condition. The sign of LFC values were then reversed so that negative LFC values indicate genes whose knockout can decrease both MHC-I associated proteins and PD-L1 protein expression levels<br />

## **Original Figures**
```{r, echo=FALSE, out.width='100%', fig.align='left', fig.cap=''}
knitr::include_graphics("assets/original_fig/33589424_XShirleyLiu_CancerDiscov_2021_overview.png", error = FALSE)
```
```{r, echo=FALSE, out.width='35%', fig.align='left', fig.cap=''}
knitr::include_graphics("assets/original_fig/33589424_XShirleyLiu_CancerDiscov_2021_B16F10_posScreen.MHCI.low+PDL1.low_Sorting_SKCM.png", error = FALSE)
```
```{r, echo=FALSE, out.width='70%', fig.align='left', fig.cap=''}
knitr::include_graphics("assets/original_fig/33589424_XShirleyLiu_CancerDiscov_2021_B16F10_posScreen.MHCI.low+PDL1.low_Sorting_SKCM.table.png", error = FALSE)
```

-----

## **MAGeCK-VISPR Results** {.tabset}
### Processed - Rank Plot
```{r, echo=FALSE, out.width='75%', fig.align='left', fig.cap=''}
knitr::include_graphics('assets/median_scaled_QC/RankPlot/33589424_XShirleyLiu_CancerDiscov_2021_B16F10_M2.posScreen.MHCI.low+PDL1.low_Sorting_SKCM.png', error = FALSE)
```

-----

### Raw - Rank Plot
```{r, echo=FALSE, out.width='75%', fig.align='left', fig.cap=''}
knitr::include_graphics('assets/RRA_QC/RankPlot/33589424_XShirleyLiu_CancerDiscov_2021_B16F10_M2.posScreen.MHCI.low+PDL1.low_Sorting_SKCM.png', error = FALSE)
```

-----

### Raw - Volcano Plot
```{r, echo=FALSE, out.width='75%', fig.align='left', fig.cap=''}
knitr::include_graphics('assets/RRA_QC/VolcanoPlot/33589424_XShirleyLiu_CancerDiscov_2021_B16F10_M2.posScreen.MHCI.low+PDL1.low_Sorting_SKCM.png', error = FALSE)
```

-----

# 33589424 | XShirleyLiu | CancerDiscov | 2021 |  B16F10 | M1.posScreen.PDL1.low
## **Overview**
**PMID**: 33589424<br />
**Model**: B16F10 (murine skin melanoma cell line)<br />
**Treatment**: Positive regulators screens. B16F10 cells was pretreated with 10ng/ml IFNγ (high dose) followed by CRISPR screen using M1 library, and then sorted with PD-L1.low condition<br />
**Control**: Unsorted population<br />
**Type**: Sorting<br />
**Description**: CRISPR screen in mouse B16F10 cells pretreated with high dose IFNγ and sorted with PD-L1.low vs. unsorted condition. The sign of LFC values were then reversed so that negative LFC values indicate genes whose knockout can decrease PD-L1 protein expression level<br />

## **Original Figures**
```{r, echo=FALSE, out.width='100%', fig.align='left', fig.cap=''}
knitr::include_graphics("assets/original_fig/33589424_XShirleyLiu_CancerDiscov_2021_overview.png", error = FALSE)
```
```{r, echo=FALSE, out.width='70%', fig.align='left', fig.cap=''}
knitr::include_graphics("assets/original_fig/33589424_XShirleyLiu_CancerDiscov_2021_B16F10_posScreen.PDL1.low_Sorting_SKCM.table.png", error = FALSE)
```

-----

## **MAGeCK-VISPR Results** {.tabset}
### Processed - Rank Plot
```{r, echo=FALSE, out.width='75%', fig.align='left', fig.cap=''}
knitr::include_graphics('assets/median_scaled_QC/RankPlot/33589424_XShirleyLiu_CancerDiscov_2021_B16F10_M1.posScreen.PDL1.low_Sorting_SKCM.png', error = FALSE)
```

-----

### Raw - Rank Plot
```{r, echo=FALSE, out.width='75%', fig.align='left', fig.cap=''}
knitr::include_graphics('assets/RRA_QC/RankPlot/33589424_XShirleyLiu_CancerDiscov_2021_B16F10_M1.posScreen.PDL1.low_Sorting_SKCM.png', error = FALSE)
```

-----

### Raw - Volcano Plot
```{r, echo=FALSE, out.width='75%', fig.align='left', fig.cap=''}
knitr::include_graphics('assets/RRA_QC/VolcanoPlot/33589424_XShirleyLiu_CancerDiscov_2021_B16F10_M1.posScreen.PDL1.low_Sorting_SKCM.png', error = FALSE)
```

-----

# 33589424 | XShirleyLiu | CancerDiscov | 2021 |  B16F10 | M2.posScreen.PDL1.low
## **Overview**
**PMID**: 33589424<br />
**Model**: B16F10 (murine skin melanoma cell line)<br />
**Treatment**: Positive regulators screens. B16F10 cells was pretreated with 10ng/ml IFNγ (high dose) followed by CRISPR screen using M2 library, and then sorted with PD-L1.low condition<br />
**Control**: Unsorted population<br />
**Type**: Sorting<br />
**Description**: CRISPR screen in mouse B16F10 cells pretreated with high dose IFNγ and sorted with PD-L1.low vs. unsorted condition. The sign of LFC values were then reversed so that negative LFC values indicate genes whose knockout can decrease PD-L1 protein expression level<br />

## **Original Figures**
```{r, echo=FALSE, out.width='100%', fig.align='left', fig.cap=''}
knitr::include_graphics("assets/original_fig/33589424_XShirleyLiu_CancerDiscov_2021_overview.png", error = FALSE)
```
```{r, echo=FALSE, out.width='70%', fig.align='left', fig.cap=''}
knitr::include_graphics("assets/original_fig/33589424_XShirleyLiu_CancerDiscov_2021_B16F10_posScreen.PDL1.low_Sorting_SKCM.table.png", error = FALSE)
```

-----

## **MAGeCK-VISPR Results** {.tabset}
### Processed - Rank Plot
```{r, echo=FALSE, out.width='75%', fig.align='left', fig.cap=''}
knitr::include_graphics('assets/median_scaled_QC/RankPlot/33589424_XShirleyLiu_CancerDiscov_2021_B16F10_M2.posScreen.PDL1.low_Sorting_SKCM.png', error = FALSE)
```

-----

### Raw - Rank Plot
```{r, echo=FALSE, out.width='75%', fig.align='left', fig.cap=''}
knitr::include_graphics('assets/RRA_QC/RankPlot/33589424_XShirleyLiu_CancerDiscov_2021_B16F10_M2.posScreen.PDL1.low_Sorting_SKCM.png', error = FALSE)
```

-----

### Raw - Volcano Plot
```{r, echo=FALSE, out.width='75%', fig.align='left', fig.cap=''}
knitr::include_graphics('assets/RRA_QC/VolcanoPlot/33589424_XShirleyLiu_CancerDiscov_2021_B16F10_M2.posScreen.PDL1.low_Sorting_SKCM.png', error = FALSE)
```

-----

# TBD | XShirleyLiu | TBD | 2021 |  B16F10 | M1.negScreen.MHCII.high
## **Overview**
**PMID**: TBD<br />
**Model**: B16F10 (murine skin melanoma cell line)<br />
**Treatment**: Negative regulators screens. B16F10 cells was pretreated with 0.1ng/ml IFNγ (low dose) followed by CRISPR screen using M1 library, and then sorted with MHC-II.high condition<br />
**Control**: Unsorted population<br />
**Type**: Sorting<br />
**Description**: CRISPR screen in mouse B16F10 cells pretreated with low dose IFNγ and sorted with MHC-II.high vs. unsorted condition. Positive LFC values indicate genes whose knockout can increase MHC-II associated proteins expression levels<br />

## **Original Figures**
```{r, echo=FALSE, out.width='100%', fig.align='left', fig.cap=''}
knitr::include_graphics("assets/original_fig/TBD_XShirleyLiu_TBD_2021_overview.png", error = FALSE)
```

-----

## **MAGeCK-VISPR Results** {.tabset}
### Processed - Rank Plot
```{r, echo=FALSE, out.width='75%', fig.align='left', fig.cap=''}
knitr::include_graphics('assets/median_scaled_QC/RankPlot/TBD_XShirleyLiu_TBD_2021_B16F10_M1.negScreen.MHCII.high_Sorting_SKCM.png', error = FALSE)
```

-----

### Raw - Rank Plot
```{r, echo=FALSE, out.width='75%', fig.align='left', fig.cap=''}
knitr::include_graphics('assets/RRA_QC/RankPlot/TBD_XShirleyLiu_TBD_2021_B16F10_M1.negScreen.MHCII.high_Sorting_SKCM.png', error = FALSE)
```

-----

### Raw - Volcano Plot
```{r, echo=FALSE, out.width='75%', fig.align='left', fig.cap=''}
knitr::include_graphics('assets/RRA_QC/VolcanoPlot/TBD_XShirleyLiu_TBD_2021_B16F10_M1.negScreen.MHCII.high_Sorting_SKCM.png', error = FALSE)
```

-----

# TBD | XShirleyLiu | TBD | 2021 |  B16F10 | M2.negScreen.MHCII.high
## **Overview**
**PMID**: TBD<br />
**Model**: B16F10 (murine skin melanoma cell line)<br />
**Treatment**: Negative regulators screens. B16F10 cells was pretreated with 0.1ng/ml IFNγ (low dose) followed by CRISPR screen using M2 library, and then sorted with MHC-II.high condition<br />
**Control**: Unsorted population<br />
**Type**: Sorting<br />
**Description**: CRISPR screen in mouse B16F10 cells pretreated with low dose IFNγ and sorted with MHC-II.high vs. unsorted condition. Positive LFC values indicate genes whose knockout can increase MHC-II associated proteins expression levels<br />

## **Original Figures**
```{r, echo=FALSE, out.width='100%', fig.align='left', fig.cap=''}
knitr::include_graphics("assets/original_fig/TBD_XShirleyLiu_TBD_2021_overview.png", error = FALSE)
```

-----

## **MAGeCK-VISPR Results** {.tabset}
### Processed - Rank Plot
```{r, echo=FALSE, out.width='75%', fig.align='left', fig.cap=''}
knitr::include_graphics('assets/median_scaled_QC/RankPlot/TBD_XShirleyLiu_TBD_2021_B16F10_M2.negScreen.MHCII.high_Sorting_SKCM.png', error = FALSE)
```

-----

### Raw - Rank Plot
```{r, echo=FALSE, out.width='75%', fig.align='left', fig.cap=''}
knitr::include_graphics('assets/RRA_QC/RankPlot/TBD_XShirleyLiu_TBD_2021_B16F10_M2.negScreen.MHCII.high_Sorting_SKCM.png', error = FALSE)
```

-----

### Raw - Volcano Plot
```{r, echo=FALSE, out.width='75%', fig.align='left', fig.cap=''}
knitr::include_graphics('assets/RRA_QC/VolcanoPlot/TBD_XShirleyLiu_TBD_2021_B16F10_M2.negScreen.MHCII.high_Sorting_SKCM.png', error = FALSE)
```

-----

# TBD | XShirleyLiu | TBD | 2021 |  B16F10 | M1.negScreen.MHCII.high+PDL1.high
## **Overview**
**PMID**: TBD<br />
**Model**: B16F10 (murine skin melanoma cell line)<br />
**Treatment**: Negative regulators screens. B16F10 cells was pretreated with 0.1ng/ml IFNγ (low dose) followed by CRISPR screen using M1 library, and then sorted with MHC-II.high+PD-L1.high condition<br />
**Control**: Unsorted population<br />
**Type**: Sorting<br />
**Description**: CRISPR screen in mouse B16F10 cells pretreated with low dose IFNγ and sorted with MHC-II.high+PD-L1.high vs. unsorted condition. Positive LFC values indicate genes whose knockout can increase both MHC-II associated proteins and PD-L1 protein expression levels<br />

## **Original Figures**
```{r, echo=FALSE, out.width='100%', fig.align='left', fig.cap=''}
knitr::include_graphics("assets/original_fig/TBD_XShirleyLiu_TBD_2021_overview.png", error = FALSE)
```

-----

## **MAGeCK-VISPR Results** {.tabset}
### Processed - Rank Plot
```{r, echo=FALSE, out.width='75%', fig.align='left', fig.cap=''}
knitr::include_graphics('assets/median_scaled_QC/RankPlot/TBD_XShirleyLiu_TBD_2021_B16F10_M1.negScreen.MHCII.high+PDL1.high_Sorting_SKCM.png', error = FALSE)
```

-----

### Raw - Rank Plot
```{r, echo=FALSE, out.width='75%', fig.align='left', fig.cap=''}
knitr::include_graphics('assets/RRA_QC/RankPlot/TBD_XShirleyLiu_TBD_2021_B16F10_M1.negScreen.MHCII.high+PDL1.high_Sorting_SKCM.png', error = FALSE)
```

-----

### Raw - Volcano Plot
```{r, echo=FALSE, out.width='75%', fig.align='left', fig.cap=''}
knitr::include_graphics('assets/RRA_QC/VolcanoPlot/TBD_XShirleyLiu_TBD_2021_B16F10_M1.negScreen.MHCII.high+PDL1.high_Sorting_SKCM.png', error = FALSE)
```

-----

# TBD | XShirleyLiu | TBD | 2021 |  B16F10 | M2.negScreen.MHCII.high+PDL1.high
## **Overview**
**PMID**: TBD<br />
**Model**: B16F10 (murine skin melanoma cell line)<br />
**Treatment**: Negative regulators screens. B16F10 cells was pretreated with 0.1ng/ml IFNγ (low dose) followed by CRISPR screen using M2 library, and then sorted with MHC-II.high+PD-L1.high condition<br />
**Control**: Unsorted population<br />
**Type**: Sorting<br />
**Description**: CRISPR screen in mouse B16F10 cells pretreated with low dose IFNγ and sorted with MHC-II.high+PD-L1.high vs. unsorted condition. Positive LFC values indicate genes whose knockout can increase both MHC-II associated proteins and PD-L1 protein expression levels<br />

## **Original Figures**
```{r, echo=FALSE, out.width='100%', fig.align='left', fig.cap=''}
knitr::include_graphics("assets/original_fig/TBD_XShirleyLiu_TBD_2021_overview.png", error = FALSE)
```

-----

## **MAGeCK-VISPR Results** {.tabset}
### Processed - Rank Plot
```{r, echo=FALSE, out.width='75%', fig.align='left', fig.cap=''}
knitr::include_graphics('assets/median_scaled_QC/RankPlot/TBD_XShirleyLiu_TBD_2021_B16F10_M2.negScreen.MHCII.high+PDL1.high_Sorting_SKCM.png', error = FALSE)
```

-----

### Raw - Rank Plot
```{r, echo=FALSE, out.width='75%', fig.align='left', fig.cap=''}
knitr::include_graphics('assets/RRA_QC/RankPlot/TBD_XShirleyLiu_TBD_2021_B16F10_M2.negScreen.MHCII.high+PDL1.high_Sorting_SKCM.png', error = FALSE)
```

-----

### Raw - Volcano Plot
```{r, echo=FALSE, out.width='75%', fig.align='left', fig.cap=''}
knitr::include_graphics('assets/RRA_QC/VolcanoPlot/TBD_XShirleyLiu_TBD_2021_B16F10_M2.negScreen.MHCII.high+PDL1.high_Sorting_SKCM.png', error = FALSE)
```

-----

# TBD | XShirleyLiu | TBD | 2021 |  B16F10 | M1.negScreen.PDL1.high
## **Overview**
**PMID**: TBD<br />
**Model**: B16F10 (murine skin melanoma cell line)<br />
**Treatment**: Negative regulators screens. B16F10 cells was pretreated with 0.1ng/ml IFNγ (low dose) followed by CRISPR screen using M1 library, and then sorted with PD-L1.high condition<br />
**Control**: Unsorted population<br />
**Type**: Sorting<br />
**Description**: CRISPR screen in mouse B16F10 cells pretreated with low dose IFNγ and sorted with PD-L1.high vs. unsorted condition. Positive LFC values indicate genes whose knockout can increase PD-L1 protein expression level<br />

## **Original Figures**
```{r, echo=FALSE, out.width='100%', fig.align='left', fig.cap=''}
knitr::include_graphics("assets/original_fig/TBD_XShirleyLiu_TBD_2021_overview.png", error = FALSE)
```

-----

## **MAGeCK-VISPR Results** {.tabset}
### Processed - Rank Plot
```{r, echo=FALSE, out.width='75%', fig.align='left', fig.cap=''}
knitr::include_graphics('assets/median_scaled_QC/RankPlot/TBD_XShirleyLiu_TBD_2021_B16F10_M1.negScreen.PDL1.high_Sorting_SKCM.png', error = FALSE)
```

-----

### Raw - Rank Plot
```{r, echo=FALSE, out.width='75%', fig.align='left', fig.cap=''}
knitr::include_graphics('assets/RRA_QC/RankPlot/TBD_XShirleyLiu_TBD_2021_B16F10_M1.negScreen.PDL1.high_Sorting_SKCM.png', error = FALSE)
```

-----

### Raw - Volcano Plot
```{r, echo=FALSE, out.width='75%', fig.align='left', fig.cap=''}
knitr::include_graphics('assets/RRA_QC/VolcanoPlot/TBD_XShirleyLiu_TBD_2021_B16F10_M1.negScreen.PDL1.high_Sorting_SKCM.png', error = FALSE)
```

-----

# TBD | XShirleyLiu | TBD | 2021 |  B16F10 | M2.negScreen.PDL1.high
## **Overview**
**PMID**: TBD<br />
**Model**: B16F10 (murine skin melanoma cell line)<br />
**Treatment**: Negative regulators screens. B16F10 cells was pretreated with 0.1ng/ml IFNγ (low dose) followed by CRISPR screen using M2 library, and then sorted with PD-L1.high condition<br />
**Control**: Unsorted population<br />
**Type**: Sorting<br />
**Description**: CRISPR screen in mouse B16F10 cells pretreated with low dose IFNγ and sorted with PD-L1.high vs. unsorted condition. Positive LFC values indicate genes whose knockout can increase PD-L1 protein expression level<br />

## **Original Figures**
```{r, echo=FALSE, out.width='100%', fig.align='left', fig.cap=''}
knitr::include_graphics("assets/original_fig/TBD_XShirleyLiu_TBD_2021_overview.png", error = FALSE)
```

-----

## **MAGeCK-VISPR Results** {.tabset}
### Processed - Rank Plot
```{r, echo=FALSE, out.width='75%', fig.align='left', fig.cap=''}
knitr::include_graphics('assets/median_scaled_QC/RankPlot/TBD_XShirleyLiu_TBD_2021_B16F10_M2.negScreen.PDL1.high_Sorting_SKCM.png', error = FALSE)
```

-----

### Raw - Rank Plot
```{r, echo=FALSE, out.width='75%', fig.align='left', fig.cap=''}
knitr::include_graphics('assets/RRA_QC/RankPlot/TBD_XShirleyLiu_TBD_2021_B16F10_M2.negScreen.PDL1.high_Sorting_SKCM.png', error = FALSE)
```

-----

### Raw - Volcano Plot
```{r, echo=FALSE, out.width='75%', fig.align='left', fig.cap=''}
knitr::include_graphics('assets/RRA_QC/VolcanoPlot/TBD_XShirleyLiu_TBD_2021_B16F10_M2.negScreen.PDL1.high_Sorting_SKCM.png', error = FALSE)
```

-----

# TBD | XShirleyLiu | TBD | 2021 |  B16F10 | M1.posScreen.MHCII.low
## **Overview**
**PMID**: TBD<br />
**Model**: B16F10 (murine skin melanoma cell line)<br />
**Treatment**: Positive regulators screens. B16F10 cells was pretreated with 10ng/ml IFNγ (high dose) followed by CRISPR screen using M1 library, and then sorted with MHC-II.low condition<br />
**Control**: Unsorted population<br />
**Type**: Sorting<br />
**Description**: CRISPR screen in mouse B16F10 cells pretreated with high dose IFNγ and sorted with MHC-II.low vs. unsorted condition. The sign of LFC values were then reversed so that negative LFC values indicate genes whose knockout can decrease MHC-II associated proteins expression levels<br />

## **Original Figures**
```{r, echo=FALSE, out.width='100%', fig.align='left', fig.cap=''}
knitr::include_graphics("assets/original_fig/TBD_XShirleyLiu_TBD_2021_overview.png", error = FALSE)
```

-----

## **MAGeCK-VISPR Results** {.tabset}
### Processed - Rank Plot
```{r, echo=FALSE, out.width='75%', fig.align='left', fig.cap=''}
knitr::include_graphics('assets/median_scaled_QC/RankPlot/TBD_XShirleyLiu_TBD_2021_B16F10_M1.posScreen.MHCII.low_Sorting_SKCM.png', error = FALSE)
```

-----

### Raw - Rank Plot
```{r, echo=FALSE, out.width='75%', fig.align='left', fig.cap=''}
knitr::include_graphics('assets/RRA_QC/RankPlot/TBD_XShirleyLiu_TBD_2021_B16F10_M1.posScreen.MHCII.low_Sorting_SKCM.png', error = FALSE)
```

-----

### Raw - Volcano Plot
```{r, echo=FALSE, out.width='75%', fig.align='left', fig.cap=''}
knitr::include_graphics('assets/RRA_QC/VolcanoPlot/TBD_XShirleyLiu_TBD_2021_B16F10_M1.posScreen.MHCII.low_Sorting_SKCM.png', error = FALSE)
```

-----

# TBD | XShirleyLiu | TBD | 2021 |  B16F10 | M2.posScreen.MHCII.low
## **Overview**
**PMID**: TBD<br />
**Model**: B16F10 (murine skin melanoma cell line)<br />
**Treatment**: Positive regulators screens. B16F10 cells was pretreated with 10ng/ml IFNγ (high dose) followed by CRISPR screen using M2 library, and then sorted with MHC-II.low condition<br />
**Control**: Unsorted population<br />
**Type**: Sorting<br />
**Description**: CRISPR screen in mouse B16F10 cells pretreated with high dose IFNγ and sorted with MHC-II.low vs. unsorted condition. The sign of LFC values were then reversed so that negative LFC values indicate genes whose knockout can decrease MHC-II associated proteins expression levels<br />

## **Original Figures**
```{r, echo=FALSE, out.width='100%', fig.align='left', fig.cap=''}
knitr::include_graphics("assets/original_fig/TBD_XShirleyLiu_TBD_2021_overview.png", error = FALSE)
```

-----

## **MAGeCK-VISPR Results** {.tabset}
### Processed - Rank Plot
```{r, echo=FALSE, out.width='75%', fig.align='left', fig.cap=''}
knitr::include_graphics('assets/median_scaled_QC/RankPlot/TBD_XShirleyLiu_TBD_2021_B16F10_M2.posScreen.MHCII.low_Sorting_SKCM.png', error = FALSE)
```

-----

### Raw - Rank Plot
```{r, echo=FALSE, out.width='75%', fig.align='left', fig.cap=''}
knitr::include_graphics('assets/RRA_QC/RankPlot/TBD_XShirleyLiu_TBD_2021_B16F10_M2.posScreen.MHCII.low_Sorting_SKCM.png', error = FALSE)
```

-----

### Raw - Volcano Plot
```{r, echo=FALSE, out.width='75%', fig.align='left', fig.cap=''}
knitr::include_graphics('assets/RRA_QC/VolcanoPlot/TBD_XShirleyLiu_TBD_2021_B16F10_M2.posScreen.MHCII.low_Sorting_SKCM.png', error = FALSE)
```

-----

# TBD | XShirleyLiu | TBD | 2021 |  B16F10 | M1.posScreen.MHCII.low+PDL1.low
## **Overview**
**PMID**: TBD<br />
**Model**: B16F10 (murine skin melanoma cell line)<br />
**Treatment**: Positive regulators screens. B16F10 cells was pretreated with 10ng/ml IFNγ (high dose) followed by CRISPR screen using M1 library, and then sorted with MHCII.low+PDL1.low condition<br />
**Control**: Unsorted population<br />
**Type**: Sorting<br />
**Description**: CRISPR screen in mouse B16F10 cells pretreated with high dose IFNγ and sorted withMHCII.low+PDL1.low vs. unsorted condition. The sign of LFC values were then reversed so that negative LFC values indicate genes whose knockout can decrease both MHC-II associated proteins and PD-L1 protein expression levels<br />

## **Original Figures**
```{r, echo=FALSE, out.width='100%', fig.align='left', fig.cap=''}
knitr::include_graphics("assets/original_fig/TBD_XShirleyLiu_TBD_2021_overview.png", error = FALSE)
```

-----

## **MAGeCK-VISPR Results** {.tabset}
### Processed - Rank Plot
```{r, echo=FALSE, out.width='75%', fig.align='left', fig.cap=''}
knitr::include_graphics('assets/median_scaled_QC/RankPlot/TBD_XShirleyLiu_TBD_2021_B16F10_M1.posScreen.MHCII.low+PDL1.low_Sorting_SKCM.png', error = FALSE)
```

-----

### Raw - Rank Plot
```{r, echo=FALSE, out.width='75%', fig.align='left', fig.cap=''}
knitr::include_graphics('assets/RRA_QC/RankPlot/TBD_XShirleyLiu_TBD_2021_B16F10_M1.posScreen.MHCII.low+PDL1.low_Sorting_SKCM.png', error = FALSE)
```

-----

### Raw - Volcano Plot
```{r, echo=FALSE, out.width='75%', fig.align='left', fig.cap=''}
knitr::include_graphics('assets/RRA_QC/VolcanoPlot/TBD_XShirleyLiu_TBD_2021_B16F10_M1.posScreen.MHCII.low+PDL1.low_Sorting_SKCM.png', error = FALSE)
```

-----

# TBD | XShirleyLiu | TBD | 2021 |  B16F10 | M2.posScreen.MHCII.low+PDL1.low
## **Overview**
**PMID**: TBD<br />
**Model**: B16F10 (murine skin melanoma cell line)<br />
**Treatment**: Positive regulators screens. B16F10 cells was pretreated with 10ng/ml IFNγ (high dose) followed by CRISPR screen using M2 library, and then sorted with MHCII.low+PDL1.low condition<br />
**Control**: Unsorted population<br />
**Type**: Sorting<br />
**Description**: CRISPR screen in mouse B16F10 cells pretreated with high dose IFNγ and sorted withMHCII.low+PDL1.low vs. unsorted condition. The sign of LFC values were then reversed so that negative LFC values indicate genes whose knockout can decrease both MHC-II associated proteins and PD-L1 protein expression levels<br />

## **Original Figures**
```{r, echo=FALSE, out.width='100%', fig.align='left', fig.cap=''}
knitr::include_graphics("assets/original_fig/TBD_XShirleyLiu_TBD_2021_overview.png", error = FALSE)
```

-----

## **MAGeCK-VISPR Results** {.tabset}
### Processed - Rank Plot
```{r, echo=FALSE, out.width='75%', fig.align='left', fig.cap=''}
knitr::include_graphics('assets/median_scaled_QC/RankPlot/TBD_XShirleyLiu_TBD_2021_B16F10_M2.posScreen.MHCII.low+PDL1.low_Sorting_SKCM.png', error = FALSE)
```

-----

### Raw - Rank Plot
```{r, echo=FALSE, out.width='75%', fig.align='left', fig.cap=''}
knitr::include_graphics('assets/RRA_QC/RankPlot/TBD_XShirleyLiu_TBD_2021_B16F10_M2.posScreen.MHCII.low+PDL1.low_Sorting_SKCM.png', error = FALSE)
```

-----

### Raw - Volcano Plot
```{r, echo=FALSE, out.width='75%', fig.align='left', fig.cap=''}
knitr::include_graphics('assets/RRA_QC/VolcanoPlot/TBD_XShirleyLiu_TBD_2021_B16F10_M2.posScreen.MHCII.low+PDL1.low_Sorting_SKCM.png', error = FALSE)
```

-----

# TBD | XShirleyLiu | TBD | 2021 |  B16F10 | M1.posScreen.PDL1.low
## **Overview**
**PMID**: TBD<br />
**Model**: B16F10 (murine skin melanoma cell line)<br />
**Treatment**: Positive regulators screens. B16F10 cells was pretreated with 10ng/ml IFNγ (high dose) followed by CRISPR screen using M1 library, and then sorted with PD-L1.low condition<br />
**Control**: Unsorted population<br />
**Type**: Sorting<br />
**Description**: CRISPR screen in mouse B16F10 cells pretreated with high dose IFNγ and sorted with PD-L1.low vs. unsorted condition. The sign of LFC values were then reversed so that negative LFC values indicate genes whose knockout can decrease PD-L1 protein expression level<br />

## **Original Figures**
```{r, echo=FALSE, out.width='100%', fig.align='left', fig.cap=''}
knitr::include_graphics("assets/original_fig/TBD_XShirleyLiu_TBD_2021_overview.png", error = FALSE)
```

-----

## **MAGeCK-VISPR Results** {.tabset}
### Processed - Rank Plot
```{r, echo=FALSE, out.width='75%', fig.align='left', fig.cap=''}
knitr::include_graphics('assets/median_scaled_QC/RankPlot/TBD_XShirleyLiu_TBD_2021_B16F10_M1.posScreen.PDL1.low_Sorting_SKCM.png', error = FALSE)
```

-----

### Raw - Rank Plot
```{r, echo=FALSE, out.width='75%', fig.align='left', fig.cap=''}
knitr::include_graphics('assets/RRA_QC/RankPlot/TBD_XShirleyLiu_TBD_2021_B16F10_M1.posScreen.PDL1.low_Sorting_SKCM.png', error = FALSE)
```

-----

### Raw - Volcano Plot
```{r, echo=FALSE, out.width='75%', fig.align='left', fig.cap=''}
knitr::include_graphics('assets/RRA_QC/VolcanoPlot/TBD_XShirleyLiu_TBD_2021_B16F10_M1.posScreen.PDL1.low_Sorting_SKCM.png', error = FALSE)
```

-----

# TBD | XShirleyLiu | TBD | 2021 |  B16F10 | M2.posScreen.PDL1.low
## **Overview**
**PMID**: TBD<br />
**Model**: B16F10 (murine skin melanoma cell line)<br />
**Treatment**: Positive regulators screens. B16F10 cells was pretreated with 10ng/ml IFNγ (high dose) followed by CRISPR screen using M2 library, and then sorted with PD-L1.low condition<br />
**Control**: Unsorted population<br />
**Type**: Sorting<br />
**Description**: CRISPR screen in mouse B16F10 cells pretreated with high dose IFNγ and sorted with PD-L1.low vs. unsorted condition. The sign of LFC values were then reversed so that negative LFC values indicate genes whose knockout can decrease PD-L1 protein expression level<br />

## **Original Figures**
```{r, echo=FALSE, out.width='100%', fig.align='left', fig.cap=''}
knitr::include_graphics("assets/original_fig/TBD_XShirleyLiu_TBD_2021_overview.png", error = FALSE)
```

-----

## **MAGeCK-VISPR Results** {.tabset}
### Processed - Rank Plot
```{r, echo=FALSE, out.width='75%', fig.align='left', fig.cap=''}
knitr::include_graphics('assets/median_scaled_QC/RankPlot/TBD_XShirleyLiu_TBD_2021_B16F10_M2.posScreen.PDL1.low_Sorting_SKCM.png', error = FALSE)
```

-----

### Raw - Rank Plot
```{r, echo=FALSE, out.width='75%', fig.align='left', fig.cap=''}
knitr::include_graphics('assets/RRA_QC/RankPlot/TBD_XShirleyLiu_TBD_2021_B16F10_M2.posScreen.PDL1.low_Sorting_SKCM.png', error = FALSE)
```

-----

### Raw - Volcano Plot
```{r, echo=FALSE, out.width='75%', fig.align='left', fig.cap=''}
knitr::include_graphics('assets/RRA_QC/VolcanoPlot/TBD_XShirleyLiu_TBD_2021_B16F10_M2.posScreen.PDL1.low_Sorting_SKCM.png', error = FALSE)
```

-----
